4-(Bromomethyl)-1-methyl-2-(trifluoromethyl)benzene

Catalog No. :
ACXLCY235
CAS No. :
261952-19-6
Molecular Formula :
C9H8BrF3
Molecular Weight :
253.06

IUPAC Name:4-(bromomethyl)-1-methyl-2-(trifluoromethyl)benzene

4-(Bromomethyl)-1-methyl-2-(trifluoromethyl)benzene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$95.00Login to see priceIn stockInquiry
5g95%$304.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(Bromomethyl)-1-methyl-2-(trifluoromethyl)benzene
IUPAC Name4-(bromomethyl)-1-methyl-2-(trifluoromethyl)benzene
MDL No.MFCD01631612
Molecular FormulaC9H8BrF3
Molecular Weight253.06
SMILESFC(C1=CC(CBr)=CC=C1C)(F)F
InChI KeyDEGVSFJBDJUTBP-UHFFFAOYSA-N
Synonym4-(Bromomethyl)-1-methyl-2-(trifluoromethyl)benzene;4-(Bromomethyl)-1-methyl-2-(trifluoromethyl)benzene, 5-(Bromomethyl)-2-methylbenzotrifluoride;4-METHYL-3-(TRIFLUOROMETHYL)BENZYL BROMIDE;Benzene, 4-(bromomethyl)-1-methyl-2-(trifluoromethyl)-
CAS No.261952-19-6
PubChem CID2775627

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H314
Precautionary Statement(s)
P260-P264-P270-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P363-P405-P501

Synthetic Route by SureRoute

1. ACXLCY235 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXLCY235 route product structure diagram
    ACXLCY235261952-19-6 In Stock
Inquiry

2. ACXLCY235 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXLCY235 route product structure diagram
    ACXLCY235261952-19-6 In Stock
Inquiry

Comments (0)